Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diacylglycerol kinase iota is an enzyme that phosphorylates the lipid messenger diacylglycerol (DAG) to produce phosphatidic acid (PA), regulating the respective levels of these two important bioactive lipids[2][3][5][6][7]. This activity is central to lipid metabolism and signal transduction in eukaryotic cells[1][2][3][6]. DGKI belongs to a conserved family of DGKs characterized by a catalytic domain and multiple cysteine-rich (C1) domains[1][5]. Tissue expression studies show particularly high levels in the brain and retina, suggesting a role in the central nervous system and visual processing[4][5]. Dysregulation of diacylglycerol kinase enzymes, including DGKI, has been connected to cancer and metabolic diseases[1]. The human protein is encoded by the DGKI gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diacylglycerol kinase iota (DGKI).